Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of perioperative CA19‐9 change on the survival and recurrence patterns after adjuvant chemoradiotherapy in resectable extrahepatic cholangiocarcinoma
Byoung Hyuck Kim, Eunji Kim, Kyubo Kim, et al.
Journal of Surgical Oncology (2017) Vol. 117, Iss. 3, pp. 380-388
Closed Access | Times Cited: 15

Showing 15 citing articles:

Current standards and future perspectives in adjuvant treatment for biliary tract cancers
Ángela Lamarca, Julien Edeline, Mairéad G. McNamara, et al.
Cancer Treatment Reviews (2019) Vol. 84, pp. 101936-101936
Open Access | Times Cited: 100
Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer
Alessandro Rizzo, Giovanni Brandi
Expert Review of Gastroenterology & Hepatology (2021) Vol. 15, Iss. 5, pp. 547-554
Closed Access | Times Cited: 79
Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinoma
Louisa Bolm, Ekaterina Petrova, Jürgen Weitz, et al.
HPB (2019) Vol. 21, Iss. 11, pp. 1513-1519
Open Access | Times Cited: 32
The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
Eleni Gkika, M. Hawkins, Anca‐Ligia Grosu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 27
Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma
Hua Yang, Jie Wang, Zehuan Li, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 25
The Plasma LncRNA Acting as Fingerprint in Hilar Cholangiocarcinoma
Jian Shi, Xiaohua Li, Fan Zhang, et al.
Cellular Physiology and Biochemistry (2018) Vol. 49, Iss. 5, pp. 1694-1702
Open Access | Times Cited: 22
A Transcriptomic Signature for Risk‐Stratification and Recurrence Prediction in Intrahepatic Cholangiocarcinoma
Yuma Wada, Mitsuo Shimada, Kensuke Yamamura, et al.
Hepatology (2021) Vol. 74, Iss. 3, pp. 1371-1383
Open Access | Times Cited: 16
Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directions
Alessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100334-100334
Open Access | Times Cited: 15
Prognostic Value of Carbohydrate Antigen 19‐9 and the Surgical Margin in Extrahepatic Cholangiocarcinoma
Ryusei Yamamoto, Teiichi Sugiura, Ryo Ashida, et al.
Annals of Gastroenterological Surgery (2021) Vol. 6, Iss. 2, pp. 307-315
Open Access | Times Cited: 13
Development and validation of an online calculator to predict early recurrence and long‐term survival in patients with distal cholangiocarcinoma after pancreaticoduodenectomy
Shuai Xu, Xiu‐Ping Zhang, Guodong Zhao, et al.
Journal of Hepato-Biliary-Pancreatic Sciences (2021) Vol. 29, Iss. 11, pp. 1214-1225
Closed Access | Times Cited: 11
Predictors of postoperative early recurrence of extrahepatic bile duct cancer
Masayuki Akita, Tetsuo Ajiki, Kimihiko Ueno, et al.
Surgery Today (2019) Vol. 50, Iss. 4, pp. 344-351
Closed Access | Times Cited: 10
Surgical Management of Hilar Cholangiocarcinoma
Alexander Fisher, Sean M. Ronnekleiv‐Kelly
Current Surgery Reports (2018) Vol. 6, Iss. 8
Closed Access | Times Cited: 5
Evaluation of the utility of prognostic models for patients with resected hilar cholangiocarcinoma
N. Bird, N Manu, Leonard Quinn, et al.
HPB (2019) Vol. 21, Iss. 10, pp. 1376-1384
Open Access | Times Cited: 4
Research progress and prospect of postoperative adjuvant therapy for resectable intrahepatic cholangiocarcinoma
Yanxin Sun, Wei Jiang, Ruiheng Duan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Studying of serum bile acids metabolomics as potential biomarkers for differentiation between hepatocellular carcinoma and cholangiocarcinoma
Azza Mahmoud El Sheashaey, Mounzer Agha, Aliaa Shalaby, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access
Page 1

Scroll to top